AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kazia Therapeutics

0.080

0.000

Volume:- -

Turnover:33.88K

Market Cap:18.91M

PE:-0.71

High:0.080

Open:0.080

Low:0.080

Close:0.080

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Kazia Therapeutics

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.kaziatherapeutics.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is headquartered in Sydney, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KZA.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KZA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KZA.AU\",,,,,undefined,":{"symbol":"KZA.AU","market":"AU","secType":"STK","nameCN":"Kazia Therapeutics","latestPrice":0.08,"timestamp":1752818400000,"preClose":0.08,"halted":0,"volume":0,"delay":0,"nameEN":"Kazia Therapeutics","floatShares":152242274,"shares":236349374,"eps":-0.1123,"marketStatus":"Pre CSPA","change":0,"latestTime":"07-18 16:01:35 AEST","open":0.08,"high":0.08,"low":0.08,"amount":33880.361109686,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.1123,"tradingStatus":3,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":13,"adr":0,"exchange":"ASX","adjPreClose":0.08,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KZA.AU\",,,,,undefined,":{"symbol":"KZA.AU","floatShares":152242274,"roa":"-47.18%","roe":"-134.97%","lyrEps":-0.111052,"shares":236349374,"dividePrice":0,"high":0.08,"amplitude":0,"preClose":0.08,"low":0.08,"week52Low":0.08,"pbRate":"1.57","psRate":"34068.38","week52High":0.08,"institutionHeld":0,"latestPrice":0.08,"eps":-0.1123,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.1123,"open":0.08,"prevYearClose":0.08,"prevWeekClose":0.08,"prevMonthClose":0.08,"prevQuarterClose":0.08,"fiveDayClose":0.08,"twentyDayClose":0.08,"sixtyDayClose":0.08},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.kaziatherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0105},{"period":"3month","weight":0.078},{"period":"6month","weight":0.1385},{"period":"1year","weight":0.2118},{"period":"ytd","weight":0.1554}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is headquartered in Sydney, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.275862,"avgChangeRate":-0.016982},{"month":2,"riseRate":0.448276,"avgChangeRate":0.036961},{"month":3,"riseRate":0.310345,"avgChangeRate":0.006758},{"month":4,"riseRate":0.310345,"avgChangeRate":0.024851},{"month":5,"riseRate":0.448276,"avgChangeRate":-0.05027},{"month":6,"riseRate":0.275862,"avgChangeRate":-0.026314},{"month":7,"riseRate":0.413793,"avgChangeRate":0.008717},{"month":8,"riseRate":0.37931,"avgChangeRate":-0.007956},{"month":9,"riseRate":0.266667,"avgChangeRate":-0.039525},{"month":10,"riseRate":0.433333,"avgChangeRate":0.041401},{"month":11,"riseRate":0.448276,"avgChangeRate":0.073326},{"month":12,"riseRate":0.62069,"avgChangeRate":0.111447}],"exchange":"ASX","name":"Kazia Therapeutics","nameEN":"Kazia Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KZA.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KZA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KZA.AU\",market:\"AU\",,,undefined,":[]}}